All In Biotech

Drug Trial Radar · NCT05122169

Skip Prep of Vaginal Delivery to Prevent Puerperal / Perinatal Infection in Vaginal Delivery

Establishment of Clinical Practice Guideline to Prevent Puerperal / Perinatal Infection in Vaginal Delivery for Pregnant Women and Newborns

Last checked: Nov 20, 2026Latest source record: Nov 26, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingRandomized with 4,140 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

4,140

Planned (sponsor's estimate)

Start

Dec 2021

Primary completion

Dec 31, 2025

Study completion May 31, 2026

Sponsor

Lead sponsor
Seoul National University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 16, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
Female only, from 19 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, controlled trial study to find whether use of chlorhexidine-alcohol or povidone-iodine for pre-vaginal delivery skin prep is superior to reduce postpartum infection in pregnant women with vaginal delivery. The primary outcome is the episiotomy site infection.

Conditions

  • Vaginal Delivery
  • Surgical Site Infection

Interventions

  • Povidone-IodineDrug

    Skin preparation with povidone-iodine pre-vaginal delivery skin preparation.

  • ChlorhexidineDrug

    Skin preparation with chlorhexidine-alcohol pre-vaginal delivery skin preparation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participant with episiotomy site infectionTime frame: 21 days

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.